hace2 antibody (GeneTex)
90
Structured Review
GeneTex
hace2 antibody
Hace2 Antibody, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/advanblock+blocking+buffer/anti+hace2+antibody/pm40020261-86-33-34
Average 90 stars, based on 1 article reviews
Hace2 Antibody, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/advanblock+blocking+buffer/anti+hace2+antibody/pm40020261-86-33-34
Average 90 stars, based on 1 article reviews
hace2 antibody - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Incubation:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Infection:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Reverse Transcription Polymerase Chain Reaction:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Control:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Western Blot:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Quantitative RT-PCR:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Plaque Assay:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Virus:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Drug discovery:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Injection:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Negative Control:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Expressing:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Isolation:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Construct:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Purification:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg SDS Page:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Staining:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Enzyme-linked Immunosorbent Assay:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Binding Assay:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Concentration Assay:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Agglutination:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Sedimentation:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg Inhibition:Article Title: ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Article Snippet: To normalize the amount of Input samples, the protein concentration of clarified cell lysate from each dish was measured using Pierce BCA Protein Assay Kits (Thermo Fisher). Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in AdvanBlock-Chemi solution at 4 °C overnight: Article Title: The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination Article Snippet: After three washes with PBST, the plates were incubated with 100 μl Article Title: Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Article Snippet: The outbreak of SARS-CoV-2 infections had led to the COVID-19 pandemic which has a significant impact on global public health and the economy.. The spike (S) protein of SARS-CoV-2 contains the receptor binding domain (RBD) which binds to human angiotensin-converting enzyme 2 receptor.. Numerous RBD-based vaccines have been developed and recently focused on the induction of neutralizing antibodies against the immune evasive Omicron BQ.1.1 and XBB.1.5 subvariants. Article Title: A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. Article Snippet: Membranes were blocked with AdvanBlock-Chemi solution (Advansta) for 1 h at room temperature, and incubated with the following primary Abs diluted in www.thelancet.com Vol 113 March, 2025 AdvanBlock-Chemi solution at 4 ◦C overnight: Article Title: Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 mL of 25 mM MES-NaOH, pH 6.0 containing 100 μg Article Title: Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2 Article Snippet: The resuspended beads were centrifuged and mixed with 2.5 ml of 25 mM MES‐NaOH, pH 6.0 containing 100 μg |